The Cardiologist's PCSK9 Script: 6 Months of Frustration The 'honestly ridiculous' process William O'Neill, MD, faced for his own Rx Jun 11, 2018
Plan Announced to Simplify PCSK9 Access "Attestation" to replace one pharmacy benefit manager's extensive prior authorization for Praluent Jun 11, 2018
Diet During Pregnancy May Cut Offspring Allergy Risk Probiotics linked to reduced eczema risk; fish oil to lower risk of egg allergy May 18, 2018
Using Biology of Atopic Dermatitis to Improve Therapy Following psoriasis model of molecular targeting May 18, 2018
Evolocumab Wins FDA Approval for Stand-Alone CVD Prevention Will more patients now gain access to PCSK9 inhibitors? Apr 12, 2018
Praluent Delivers CV Event Prevention in ODYSSEY Second PCSK9 outcomes trial comes out like FOURIER -- but with mortality reduction Apr 12, 2018
NAMS: 'Take the Fear Out' of Hormone Therapy JoAnn Pinkerton, MD, breaks down the highlights of NAMS updated position statement Mar 19, 2018
Study: No Benefit for PT in Parkinson's Disease Physical therapy didn't improve function or quality of life in trial Jan 01, 2018
Parkinson's Disease: Prevalence Seen as Rising Biggest spike seen in men 70 years of age and up Jan 01, 2018
Inhaled Levodopa Cuts Motor Symptoms in Parkinson's 'Off' Episodes Drugmaker Acorda to seek FDA approval shortly Jan 01, 2018
Cognitive Dysfunction May Tell of Early Parkinson's Risk Baseline cognition associated with parkinsonism risk over 8 years Jan 01, 2018
Enthesitis Predicts Damage in PsA Severe enthesitis linked with worse peripheral and axial joint outcomes Dec 01, 2017
JAK Inhibitors Showing Promise for Many Skin Problems Conditions ranging from alopecia to vitiligo Nov 06, 2017
C-Section: Independent Risk Factor for Postpartum VTE On average, three in 1,000 women will develop VTE after procedure Nov 01, 2017
Testosterone Supplements Linked to VTE Risk Timing and duration of hormone therapy could be the issue Nov 01, 2017
Catheter-Based Tx Disappoints for Deep Vein Thrombosis Thrombolytic tx didn't cut post-thrombotic syndrome in trial Nov 01, 2017
ACC: Even Very Low Dose Rivaroxaban Prevents Recurrent VTE Results from EINSTEIN CHOICE point to new clinical pathway Nov 01, 2017
Osteoporosis Drug Use Falls Short Only about one in five postmenopausal women received appropriate meds Oct 06, 2017
Prolia Benefits Persist to a Decade in Postmenopausal Women Further decreases in nonvertebral fractures with longer treatment Oct 06, 2017
Add-On Nucala Does, and Doesn't, Reduce COPD Exacerbations Significant benefit in METREX trial but not in METREO Aug 09, 2017
Genomic Testing Helps Cancer Patients -- When Results are Used Also, liquid biopsy can ID drug-responsive tumors Jul 20, 2017
What's the Role of NSAIDs in Back Pain? Meta-analysis says "minimal" but diagnosis can confound Jul 19, 2017
Dupixent: Injection for Eczema Wins FDA Nod Approved for patients not responding to or unable to use topical agents Jul 06, 2017
HCV Treatment Can Avert Transplant Even in Severe Disease A quarter of patients with decompensated cirrhosis could safely get off waiting list Jul 05, 2017
Anti-VEGF Tx for Wet AMD Shows Benefit 5 Years Later Half of patients still had 20/40 vision or better Jun 01, 2017
AAO: Fruit and Caffeine May Reduce AMD Risk Micronutrient analysis also found protective effect of fiber, beta carotene, vitamins C and E Jun 01, 2017
More Bevacizumab Shots for AMD May Up Risk of Glaucoma Repeated injections tied to increased ocular pressure, higher rates of surgery Jun 01, 2017
Repeated Intravitreal Injections Linked to Glaucoma 7 or more bevacizumab injections per year may double risk of glaucoma surgery Jun 01, 2017
OncoBreak: 'Just Not Ready' for Hospice; Old Drugs, New Diseases News, features, and commentary about cancer-related issues May 24, 2017
FDA Panel Pans Bladder Cancer Therapy Too few patients, modest benefit cited in negative vote Mar 08, 2017
Image-Guided Radiation for Bladder Ca: New Standard of Care? Three-year rate of bladder preservation was 83% Mar 08, 2017
Stroke Risk Dooms Once-Promising Bone Drug 32% more strokes seen with odanacatib; development halted Dec 07, 2016
Novel Osteoporosis Drug Fares Well in Phase III Trial 18-month NNT of 28 for spine fracture in low-risk women Dec 07, 2016
Analysis Shows Unreliable Results in Osteoporosis Studies Study author admits fraud to Neurology Dec 07, 2016